Yilmaz, D. Et Al. 2014. The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction. UROLOGY , vol.83, no.2 .

Yilmaz, D., Bayatli, N., Un, O., Kadowitz, P. J., Sikka, S. C., & GÜR, S., (2014). The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction. UROLOGY , vol.83, no.2.

Yilmaz, Didem Et Al. "The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction," UROLOGY , vol.83, no.2, 2014

Yilmaz, Didem Et Al. "The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction." UROLOGY , vol.83, no.2, 2014

Yilmaz, D. Et Al. (2014) . "The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction." UROLOGY , vol.83, no.2.

@article{article, author={Didem Yilmaz Et Al. }, title={The Effect of Intracavernosal Avanafil, a Newer Phosphodiesterase-5 Inhibitor, on Neonatal Type 2 Diabetic Rats With Erectile Dysfunction}, journal={UROLOGY}, year=2014}